Literature DB >> 12707596

Macular thickness measurements in healthy subjects with different axial lengths using optical coherence tomography.

Yoshikatsu Wakitani1, Mikio Sasoh, Masahiko Sugimoto, Yoshikazu Ito, Masashi Ido, Yukiyaka Uji.   

Abstract

PURPOSE: To evaluate the retinal thickness of the macula in healthy subjects with different axial lengths.
METHODS: Included were 203 healthy subjects (116 males and 87 females). The axial length of the eyes ranged from 22.68 to 30.22 mm. Four optical coherence tomograms were obtained in a radial spoke pattern centered on the central fovea. Retinal thickness was calculated from the inner and outer retinal boundaries. The average retinal thickness in three circular areas surrounding the central fovea (350, 1,850, and 2,850 microm in diameter) was determined.
RESULTS: The retinal thickness in the three circular areas was not significantly correlated with the axial length of the eye (P = 0.10, P = 0.39, and P = 0.12). There also was no statistically significant difference found between the average thickness in emmetropic and low myopic, mildly myopic, and highly myopic eyes in the three circular areas (P = 0.35, P = 0.38, and P = 0.14).
CONCLUSION: When eyes with pathologic myopia were excluded, the axial length of the eye was found not to influence the average retinal thickness in the macular area.

Entities:  

Mesh:

Year:  2003        PMID: 12707596     DOI: 10.1097/00006982-200304000-00007

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  46 in total

1.  Postnatal maturation of the fovea in Macaca mulatta using optical coherence tomography.

Authors:  Nimesh B Patel; Li-Fang Hung; Ronald S Harwerth
Journal:  Exp Eye Res       Date:  2017-08-02       Impact factor: 3.467

2.  Spectral-domain optical coherence tomography of macula in myopia.

Authors:  Janejit Choovuthayakorn; Taksaorn Laowong; Nawat Watanachai; Direk Patikulsila; Voraporn Chaikitmongkol
Journal:  Int Ophthalmol       Date:  2015-08-20       Impact factor: 2.031

3.  Optical coherence tomography guided retreatment of photodynamic therapy.

Authors:  I Krebs; S Binder; U Stolba; K Schmid; C Glittenberg; W Brannath; A Goll
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Modelling the normal retinal nerve fibre layer thickness as measured by Stratus optical coherence tomography.

Authors:  Jesper Leth Hougaard; Carl Ostenfeld; Anders Heijl; Boel Bengtsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

5.  The role of heredity in determining central retinal thickness.

Authors:  S H Melissa Liew; Clare E Gilbert; Tim D Spector; John Marshall; Christopher J Hammond
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

6.  Normative database of retinal nerve fiber layer and macular retinal thickness in a Thai population.

Authors:  Anita Manassakorn; Winai Chaidaroon; Somsanguan Ausayakhun; Soontaree Aupapong; Sopa Wattananikorn
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

7.  Estimating retinal nerve fiber layer thickness in normal schoolchildren with spectral-domain optical coherence tomography.

Authors:  Der-Chong Tsai; Nicole Huang; Jinn-Jong Hwu; Ruo-Nan Jueng; Pesus Chou
Journal:  Jpn J Ophthalmol       Date:  2012-05-23       Impact factor: 2.447

Review 8.  Advances of optical coherence tomography in myopia and pathologic myopia.

Authors:  D S C Ng; C Y L Cheung; F O Luk; S Mohamed; M E Brelen; J C S Yam; C W Tsang; T Y Y Lai
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

9.  Objectively Measured Light Exposure During School and Summer in Children.

Authors:  Lisa A Ostrin; Auzita Sajjadi; Julia S Benoit
Journal:  Optom Vis Sci       Date:  2018-04       Impact factor: 1.973

10.  Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.

Authors:  Alexandra Wexler; Trond Sand; Tor B Elsås
Journal:  BMC Ophthalmol       Date:  2010-05-13       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.